Patients taking a GLP-1 for diabetes have a lower risk for AF at 3 years than those on other medications, report ...

Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep ...

In study after study, injected GLP-1 weight loss medications appear to work better on average for women than they do for men.

Renata D'Agrella didn't need weight loss medication to feel confident, but starting on Zepbound helped her control her health ...

For those preferring a drug-free approach to weight loss, research shows that certain nutrients and dietary strategies can naturally mimic the effects of semaglutides.

Former FDA Commissioner Dr. David Kessler has just released an important new book on diet and wieght loss. He spoke to Forbes ...

Losing weight after a years-long struggle, this letter writer gave credit to the method — then came the judgmental comments.

Trials have confirmed the efficacy of GLP-1 RAs in achieving clinically sustained weight loss in people with obesity without diabetes.

Among patients with diabetes who underwent PCI after an acute heart attack, those taking a GLP-1 had better survival rates ...

Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes ...

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) may cut the risk of obesity-related cancer (ORC) in patients being ...

GLP-1 RAs were associated with significant reductions in body weight, BMI, and waist circumference among pediatric patients with obesity.